Angiogenesis in non-small cell lung cancer: Microvessel area in needle biopsy in vascular tumor density

Analytical and Quantitative Cytology and Histology

Volumn 30, Issue 2, 2008, Pages 83-91

  Dreher Irion, Luciane C ^d,f   Prolla, João Carlos ^b   Hartmann, Antônio A ^a   Irion, Klaus L ^e   Da Silva, Vinícius D ^c  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b Clinical Hospital of Porto Alegre   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^e LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^f MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Angiogenesis; carcinoma; Non small cell

Indexed keywords

CD34 ANTIBODY;

ADULT; AGED; ARTICLE; COMPUTER ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; MICROVASCULATURE; NEEDLE BIOPSY; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC;

EID: 41849125679     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. American Lung Association: Lung cancer fact sheet. April, 2005. Available at www.lungusa.org/site/pp.asp?c=dvLUK9O0E&b=669263
2. Franklin WA: Pathology of lung cancer. J Thorac Imaging 2000;15:3-12
3. Wisnivesky JP, Henschke C, McGinn T, Iannuzzi MC: Prognosis of stage II non-small cell lung cancer according to tumor and nodal status at diagnosis. Lung Cancer 2005;49:181-186
4. Cagini L, Monacelli M, Giustozzi G, Moggi L, Bellezza G, Sidoni A, Bucciarelli E, Darwash S, Ludovini V, Pistola L, Gregore V, Tonato M: Biologic prognostic factors for early stage completely resected non-small cell lung cancer. J Surg Oncol 2000;74:53-60
5. Mattern J, Koomagi R, Volm M: Biological characterization of subgroups of squamous cell lung carcinomas. Clin Cancer Res 1999;5:1459-1463
6. Takeda S, Fukai S, Komatsu H, Nemoto E, Nakamura K, Murakami M, Japanese National Chest Hospital Study Group: Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Ann Thorac Surg 2005;79:1142-1146
7. Chiba Y, Taniguchi T, Matsuyama K, Sasaki M, Kato Y, Tanaka H, Muraoka R, Tanigawa N: Tumor angiogenesis, apoptosis, and p53 oncogene in stage I lung adenocarcinoma. Surg Today 1999;29:1148-1153
8. D'Amico TA, Aloia TA, Moore MB, Herdon JE 2nd, Brooks KR, Lau CL, Harpole DH Jr. Molecular biologic substaging of stage I lung cancer according to gender and histology. Ann Thorac Surg 2000;69:882-886
9. Harpole DJ Jr, Herndon J 2nd, Wolfe WG, Iglehart JD, Marks JR: A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 1995;55:51-56
10. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6
11. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409
12. Depasquale I, Thompson WD: Microvessel density for melanoma prognosis. Histopathology 2005;47;186-194
13. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8
14. Cox G, Jones JL, Walker RA, Steward WP, O'Byrne KJ: Angiogenesis and non-small cell lung cancer. Lung Cancer 2000;27:81-100
15. Herbst RS, Onn A, Sandler A: Angiogenesis and lung cancer: Prognostic and therapeutic implications. J Clin Oncol 2005;23:3243-3256
16. Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971;285:1182-1186
17. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE: The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.00 mm thick) skin melanoma: A quantitative histologic study. Am J Pathol 1988;133:419-423
18. Gasparini G, Weidner N, Maluta S, Pozza F, Borrachi P, Mezzetti M, Testolin A, Bevialacqua P: Intratumoral microvessel density and p53 protein: Correlation with metastasis in head-and-neck squamous cell carcinoma. Int J Cancer 1993;55:739-744
19. Tanigawa N, Amaya H, Matsumuru M, Shimomatsuya T, Honuchi T, Muraoka R, Ika M: Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 1996;56:2671-2676
20. Tarta C, Teixeira CR, Tanaka S, Haruma K, Chiele-Neto C, da Silva VD: Angiogenesis in advanced colorectal adenocarcinoma with special reference to tumoral invasion. Arq Gastroenterol 2002;39:32-38
21. Tjalma W, Van Marck E, Weyler J, Dirix L, Van Daele A, Goovaerts G, Albertyn G, van Dam P: Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer 1998;78:170-174
22. Ozalp S, Yalcin OT, Acikalin M, Tanir HM, Oner U, Akkoyanlu A: Microvessel density (MVD) as a prognosticator in endometrial carcinoma. Eur J Gynaecol Oncol 2003;24;305-308
23. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA: Relation of neovascularization to metastasis of non small cell lung cancer. Lancet 1992;340:145-146
24. Angeletti C, Lucchi M, Fontanini G, Mussi A, Luchi M, Chiné S, Angeletti CA, Harris AL, Bevilacqua G: Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2): Impact of adjuvant therapies in a subset of patients at high risk of recurrence. Cancer 1996;78:409-415
25. Irion LCD, Prolla JC, Hartmann AA, Silva VD: A determinação quantitativa da area de microvasos intratumorais pode ser um indicador útil para tratamento coadjuvante em carcinomas de células não pequenas operados do pulmão. Rev Port Pneumol 2003;IX:19-32
26. Fontanini G, Lucchi M, Vignati S, Mussi A, Cardiello F, De Laurentiis M, De Placido S, Basolo F, Angeletti CA, Bevilacqua G: Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study. J Natl Cancer Inst 1997;89:881-886
27. Szöke T, Kayser K, Baumhäkel JD, Trojan I, Furak J, Tiszlavicz L, Eller J, Boda K: Prognostic significance of microvascularization in cases of operated lung cancer. Eur J Cardiothorac Surg 2005;27:1106-1111
28. Giatromanolaki A, Koukourakis M, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC: Comparative evaluation of angiogenesis assessment with anti-factor VIII and anti-CD 31 immunostaining in non-small cell lung cancer. Clin Cancer Res 1997;3:2485-2492
29. Mineo TC, Ambrogi V, Baldi A, Rabitti C, Bollero P, Vincenzi B, Tonini G: Prognostic impact of VEGF, CD 31, CD 34, and CD 105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol 2004;57:591-597
30. Sharma S, Sharma M, Sarkar C: Morphology of angiogenesis in human cancer: A conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005;46:481-489
31. Tanaka F, Otake Y, Yanagihara K, Kawano Y, Myahara R, Li M, Yamada T, Hanaoka N, Inui K, Wada H: Evaluation of angiogenesis in non-small cell lung cancer: Comparison between anti-CD 34 antibody and anti-CD 105 antibody. Clin Cancer Res 2001;7;3410-3415
32. Fox SB, Harris AL: Histological quantitation of tumour angiogenesis. APMIS 2004;112:413-430
33. Pavlopoulos P, Konstantinidou A, Agapitos E, Kavantzas N, Nikolopoulou P, Davaris P: A morphometric study of neovascularization in colorectal carcinoma. Cancer 1998;83:2067-2075
34. Yorukoglu K, Sagol O, Ozkara E, Mungan U, Kirkali Z: Comparison of microvascularization in diagnostic needle biopsies and radical prostatectomies in prostate carcinoma. Eur Urol 1999;35:109-112
35. Bostwick DG, Wheeler TM, Blute M, Barrett DM, MacLennan GT, Sebo TJ, Scardino PT, Humphrey PA, Hudson MA, Fradet Y, Miller GJ, Crawford ED, Blumenstein BA, Mahran HE, Miles BJ: Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996;48:47-57
36. Khatami A, Pihl CG, Norrby K, Hugosson J, Damber JE: Is tumor vascularity in prostate core biopsies a predictor of PSA recurrence after radical prostatectomy? Acta Oncol 2005;44:362-368
37. Rogatsch H, Hittmair A, Reissigl A, Mikuz G, Feichtinger H: Microvessel density in core biopsies of prostatic adenocarcinoma: A stage predictor? J Pathol 1997;182:205-210
38. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, in Collaboration with Sobin LH and Pathologists from 14 countries: World Health Organization International: Histological Typing of Lung and Pleural Tumours. Third edition. Berlin, Springer-Verlag, 1999
39. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL: Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995;177:275-283
40. Hansen S, Grabau D, Sorensen F, Bak M, Vach W, Rose C: The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 2000;6:139-146
41. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezella F, Viale G, Weidner N, Harris AL, Dirix LY: Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A:2474-2484
42. Wesseling P, van der Laak JA, de Leeuw H, Ruiter DJ, Burger PC: Quantitative immunohistochemical analysis of the microvasculature in untreated human glioblastoma multiforme. J Neurosurg 1994;81:902-909
43. Fujishita A, Hasuo A, Khan KN, Masuzaki H, Nakoshima H, Ishimaru T: Immunohistochemical study of angiogenic factors in endometrium and endometriosis. Gynecol Obstet Invest 1999;48:36-44
44. Keith R, Miller Y, Gemmill R, Drabkin HA, Dempsey EC, Kennedy TC, Prindiville S, Franklin WA: Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res 2000;6:1616-1625
45. Speck N, Focchi J, Alves A, Osório C, Bacarat E: Relação entre angiogénese e o estádio do carcinoma de endométrio. Rev Bras Ginecol Obstet 2003;25:396-401
46. Blatt RJ, Clark AN, Courtney J, Tully C, Tucker AL: Automated quantitative analysis of angiogenesis in the rat aorta model using Image-Pro Plus 4.1. Comput Methods Programs Biomed 2004;75: 75-79
47. Carai A, Diaz G, Santa Cruz R, Santa Cruz G: Computerized quantitative color analysis for histological study of pulmonary fibrosis. Anticancer Res 2002;22:3889-3894
48. Goddard JC, Sutton, Furness PN, Kockelberg RC, O'Byrn KJ: A computer image analysis system for microvessel density measurement in solid tumours. Angiogenesis 2002;5:15-20
49. Meert AP, Martin B, Delmotti P, Berghmans T, Lafitte JJ, Macaux C, Paesmans M, Steels E, Verdebout JM, Sculier JP: The role of microvessel density of patients with lung cancer: A systematic review of the literature with meta-analysis. Br J Cancer 2002;87:694-701
50. Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, Albeda SM: Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review. Clin Cancer Res 2005;11:3974-3986
51. Korkolopoulou P, Patsouris E, Kavantzas N, Konstantinidiou AE, Christodoulou P, Thomas-Tsagli E, Pananikalaou A, Eftychiadis C, Pavlopoulos PM, Angelidakis D, Rologis D, Davaris P: Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol 2002;28:57-66
52. Korkolopoulou P, Konstantinidou AE, Kavantzas N, Patsouris E, Pavlopoulos PM, Christodoulou P, Thomas-Tsagli E, Davaris P: Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virchows Arch 2001;438:603-611
53. Mehaffey MG, Folberg R, Meyer M, Bentler SE, Hwang T, Woolson R, Moore KC: Relative importance of quantifying area and vascular patterns in uveal melanomas. Am J Ophthalmol 1997;123:798-809
54. Kayser G, Baumhakel JD, Szoke T, Trojan I, Riede U, Werner M, Kayser K: Vascular diffusion density and survival of patients with primary lung carcinomas. Virchows Arch 2003;442:462-467
55. Marson LP, Kurian KM, Miller WR, Dixon JM: Reproducibility of microvessel counts in breast cancer specimens. Br J Cancer 1999;81:1088-1093
56. Bostwick DG, Iczkowski KA: Microvessel density in prostate cancer. Prognostic and therapeutic utility. Semin Urol Oncol 1998;16:118-123
57. Matsuyama K, Chiba Y, Sasaki M, Tanaka H, Murakoa R, Tanigawa N: Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. Ann Thorac Surg 1998;65:1405-1409
58. Yamazaki K, Abe S, Takekawa H, Sukoh N, Watanabe N, Ogura S, Nakajima I, Isobe H, Inoue K, Kawakami Y: Tumor angiogenesis in human lung adenocarcinoma. Cancer 1994;74:2245-2250
59. Yuan A, Yang PC, Yu CJ, Lee YC, Yao YT, Chen CL, Lee LN, Kuo SH, Luh KT: Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. Am J Respir Crit Care Med 1995,152:2157-2162
60. Fontanini G, Bigini D, Vignati S, Basolo F, Mussi A, Lucchi M, Chiné S, Angeletti CA, Harris AL, Bevilacqua G: Microvessel count predicts metastatic disease and survival in non-small-cell lung cancer. J Pathol 1995;177:57-63
61. Sikora J, Slodkowska J, Radomyski A, Giedronowicz D, Kobos J, Kupis W, Rudzinski P: Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung. Rocz Akad Med Bialymst (Suppl 1) 1997;42:271-279